business news in context, analysis with attitude

The Washington Post writes that “the government is on track to approve a new antibiotic to treat a pneumonia-like disease in cattle, despite warnings from health groups and a majority of the agency's own expert advisers that the decision will be dangerous for people. The drug, called cefquinome, belongs to a class of highly potent antibiotics that are among medicine's last defenses against several serious human infections. No drug from that class has been approved in the United States for use in animals.”

The bottom line, according to critics, is that the US Food and Drug Administration (FDA) is being more deferential to the pharmaceutical companies that make antibiotics like cefquinome than it is to health experts even within its own walls. The concern, according to the Post, is that “giving cefquinome to animals would probably speed the emergence of microbes resistant to that important class of antibiotics, as has happened with other drugs. Those super-microbes could then spread to people.”
KC's View:
Gee…yet another reason to be cynical about the FDA.

Hard to imagine.